Assay Development: one of the first steps in drug development and toxicity testing is creating test systems on which to evaluate the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
-
Mammoth Biosciences is developing next-generation CRISPR platforms to build rapid, point-of-care molecular diagnostics. Our innovative DETECTR technology leverages novel CRISPR proteins whose...
As reimbursement changes and healthcare moves towards value-based models, the clinical laboratory is faced with the challenge of redefining its value outside the cost per test. This session...
Rapid, inexpensive, and sensitive nucleic acid detection may aid point-of-care pathogen detection, genotyping, and disease monitoring. We combine the RNA- targeting CRISPR effector Cas13 with...
Management of complex quality control (QC) data is essential to insure high quality patient care and maintain regulatory compliance within clinical laboratories. Robust software solutions fo...
DATE: April 3, 2019TIME: 9:00am PDT...
DATE: April 2nd, 2019TIME: 10:00AM PDTFor laboratories that operate within a quality management system, compliance with global standards such as ISO 9001, ISO 13485, ISO 17025, I...
DATE: April 2, 2019TIME: 3:00pm CEST Dans ce webinaire, Marie Piketty rappelle que depuis quelques années, plusieurs cas d'interférences provoquées par l...
Whole food plant-based diets and medical cannabis have shared and continues to share similar levels of scrutiny, doubt, and stigma by the traditional medical community. One reason for the med...